Related Experiment Video
Updated: Jan 11, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Comparisons of Left Ventricular Hypertrophy due to Essential Hypertension and Hypertrophic Non-Obstructive
Mareomi Hamada1, Sayuri Uga-Yamabe2, Shuntaro Ikeda3
1Division of Cardiology, Uwajima City Hospital.
Insights
Essential hypertension (EH) and hypertrophic non-obstructive cardiomyopathy (HNCM) both cause left ventricular hypertrophy (LVH). HNCM shows more severe myocardial ischemia and distinct LVH distribution compared to EH.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Clinical Electrophysiology
Background:
- Left ventricular hypertrophy (LVH) is a hallmark of both essential hypertension (EH) and hypertrophic non-obstructive cardiomyopathy (HNCM).
- Understanding the differences in LVH severity and distribution between EH and HNCM is crucial for accurate diagnosis and management.
Purpose of the Study:
- To compare the severity and distribution patterns of left ventricular hypertrophy (LVH) between patients with essential hypertension (EH) and hypertrophic non-obstructive cardiomyopathy (HNCM).
- To investigate the correlation between electrocardiographic findings and echocardiographic parameters in these conditions.
Main Methods:
- Included 44 patients with EH and 79 with HNCM, all exhibiting precordial negative T-waves (NTs) without LV heart failure.
- Electrocardiographic assessments included SV1 + RV5 and maximum NT depth; echocardiography measured routine indices.
- Analyzed interventricular septal thickness (IVST), LV posterior wall thickness (PWT), and LV mass index.
Main Results:
- HNCM demonstrated greater SV1 + RV5 and maximum NT depth than EH, with a significantly steeper correlation slope (4.8x) in HNCM, indicating more severe myocardial ischemia.
- Distinct NT distribution patterns were observed: V6 in EH, and V4/V5 in HNCM.
- IVST/PWT ratio was significantly higher in HNCM (1.20 ± 0.35) than EH (0.91 ± 0.10); LV mass index was similar between groups.
Conclusions:
- While LVH severity (mass index) is comparable, myocardial ischemia is more pronounced in HNCM than EH.
- The distribution pattern of LVH and associated ECG markers differ significantly between EH and HNCM, aiding in differential diagnosis.
Abstract:
Essential hypertension (EH) and hypertrophic non-obstructive cardiomyopathy (HNCM) are representative conditions associated with left ventricular hypertrophy (LVH). We compared the severity and distribution of LVH between these two conditions.This study included 44 patients with EH and 79 with HNCM exhibiting precordial negative T-waves (NTs) without LV heart failure. Electrocardiographic assessments included measurements of SV1 + RV5 and the maximum depth of NTs, and routine echocardiographic indices were measured.The SV1 + RV5 and maximum depth of NTs were greater in HNCM than in EH. A correlation was found between these two indices in both groups, with the correlation slope being 4.8 times steeper in the HNCM group. The difference in correlation slopes was considered to reflect the degree of myocardial ischemia. The maximum depth of NTs was predoinantly recorded in the V6 lead in EH, and the V4 and V5 leads in HNCM. Interventricular septal thickness (IVST) was greater in HNCM, whereas LV posterior wall thickness (PWT) was higher in EH. The IVST/PWT ratios were calculated as 0.91 ± 0.10 in EH and 1.20 ± 0.35 in HNCM (P< 0.0001). No significant difference was found in the LV mass index between the two groups. The areas under the receiver operating characteristic curve for the maximum depth of precordial NT and the maximum depth of precordial NT/SV1 + RV5 ratio were 0.967 and 0.952, respectively.LVH was similar between EH and HNCM; however, myocardial ischemia was more severe in HNCM than in EH. The distribution pattern of LVH differed markedly between these two conditions.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Mitral Regurgitation I: Introduction
Pathophysiology of Heart Failure

